Page 125 - Genentech News Today

AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee member Lausanne, Switzerland, July 26, 2023 – AC Immune SA (NASDAQ:ACIU), a clinical-stage

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a new partnership with Alnylam to develop and commercialise zilebesiran, an investigational RNAi therapeutic currently in Phase 2 for the treatment of hypertension. Hypertension affects more than 1.2 billion adults worldwide and is the main, independent ...

– ARCALYST® Q2 2023 net product revenue of $54.5 million –– ARCALYST 2023 net product revenue guidance increased to $220 - $230 million, representing ~84% year-over-year growth at the midpoint...

/PRNewswire/ -- DelveInsights Neuroendocrine Tumors Market Insights report includes a comprehensive understanding of current treatment practices,...

BIIB earnings call for the period ending June 30, 2023.

Angel Qin, MD, contextualizes the non–small cell lung cancer ADAURA trial, in which patients with EGFR-mutated non–small cell lung cancer who received adjuvant therapy with osimertinib achieved a 5-year overall survival rate of 85% vs 73% in those who received placebo.

Neil Jacobstein Chairs the AI and Robotics Track at Singularity University headquartered at the NASA Ames Research Park. He is a former President of

Marc Tessier-Lavigne, president of Stanford University in California, has announced that he was stepping down as president at the end of August but would remain a tenured professor of biology. Former dean of humanities Richard Saller will serve as interim president.1 Tessier-Lavigne, a well known neurobiologist, served as Stanford president for seven years and previously was head of the biotechnology company Genentech. In December 2022 the university’s board of trustees organised a special com...

Patients enrolled were diagnosed with refractory, metastatic or locally advanced, non-small cell lung cancer , for whom there were no other suitable treatment options Five of eight patients...

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days